Company Presentation

Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare diseases with high unmet medical need. AGAMREE® (vamorolone), a dissociative steroid with novel mode of action, was investigated in patients with Duchenne muscular dystrophy (DMD) as analternative to standard corticosteroids. It is approved in the U.S. (licensed to Catalyst Pharmaceuticals, Inc), the EU and the UK.